NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Stock Market Report: Thursday, [Date]

Market Overview The Indian stock market experienced a decline in the afternoon session on Thursday, driven by rising crude oil prices and persistent outflows of foreign funds. The Sensex dropped by 256.91 points or 0.33% to 76,606.80, while the Nifty 50 fell by 53.40 points or 0.23% to 23,807.

Market Performance The BSE benchmark index declined by 432.04 points or 0.56% to 76,459.62, while the Nifty 50 showed a loss of 129.70 points or 0.50% to 23,745.55. Foreign Institutional Investors (FIIs) sold equities valued at ₹6,267.31 crore on Wednesday, while Domestic Institutional Investors (DIIs) purchased stocks amounting to ₹4,965.53 crore.

Market Outlook According to Osho Krishan, Sr. Analyst, Technical & Derivatives, Angel One, the Nifty 50 index has resumed its bearish momentum, with a large bearish candlestick forming on Wednesday. The index has broken decisively below the crucial 24,300 zone, a level that served as significant support throughout the previous year.

Read also: Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More

Technical Analysis The 24,300 level is expected to act as immediate resistance, with the 24,500 zone presenting another strong hurdle. Unless the index manages to reclaim and sustain above these levels, any near-term bounce is likely to remain limited. On the downside, Tuesday's low near 23,700 serves as the first level of support, with a break below this opening the door toward the next important support zone near 23,500.

Stock Recommendations Osho Krishan of Angel One recommends two stocks to buy on Thursday:

  1. Wipro Ltd: A BUY recommendation with a target of ₹226-230 and a stop loss of ₹182.
  2. Dr Reddys Laboratories: A BUY recommendation with a target of ₹1,380-1,400 and a stop loss of ₹1,260.

Investor Takeaway

Investors should be cautious of the current market decline and consider near-term investment opportunities in IT and Pharma sectors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.